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Book Reviews 261
THE CODE OF CODES: SCIENTIFIC AND SOCIAL ISSUES IN
THE HUMAN GENOME PROJECT. (Daniel J. Kevles & Leroy
Hood, eds., Harvard University Press 1992) [397 pp.] Contributors,
figures, index, notes, preface, selected bibliography, tables. LC 91-38477, ISBN 0674-13645-4. [Cloth $29.95. 79 Garden Street, Cambridge MA 02138.]

This collection of essays is in three parts: (1) "History, Politics, and
Genetics," (2) "Genetics, Technology, and Medicine," and (3) "Ethics,
Law, and Society." In the preface, the editors begin by noting that a
mere 1% difference between our and ape genomes is much of the "grail
of human genetics" and end by stating the objective of stimulating
thought about the human genome project.
The first essay should be of wide interest. It describes how initial
attempts to apply genetics to humans led in the U.S. to, e.g.,
sterilization laws 1 and later to the Holocaust. This, in turn, led to
increasing scientific hostility and so tarred human genetic research that
only slowly have these associations been overcome by work, e.g., on
sickle cell anemia. It also recounts how, following identification of the
structure of DNA and an invention allowing the isolation and the
determination of functions of single human genes, it became possible to
sequence the entire human genome. One of the more interesting aspects
of this chapter, is its discussion of the mid-1980's origins of the project
within the Department of Energy and turf battles with the National
Institute of Health (NIH) that resulted, in 1991, with NIH receiving the
lion's share of funding and the task of human genetic mapping.
Following a chapter on the technological history of gene mapping
and sequencing, the second part the book describes what is necessary to
determine our "genetic blueprint" with about three billion DNA base
pairs. Three discrete phases are needed to reach that goal: breaking all of
the chromosomal DNA into fragments for physical mapping,
sequencing of all base pairs of the chromosomes, and, finally,
understanding the function of each gene. It is estimated that these phases
will require, respectively, one hundred, three to ten thousand, and one
million person-years each.
1 These were upheld in Buck v. Bell, 274 U.S. 200 (1927). At 207, Justice
Holmes, writing for the majority, opined that 'hree generations of imbecileg are
enough."
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The second part concludes with an essay by the initial project
director, James Watson, in which he extols the project's potential for
understanding and curing conditions such as Alzheimer's disease, cystic
fibrosis and alcoholism - as well as its cost-effectiveness compared to
the cost of the developing palliatives. Watson also expresses his
inability to reconcile patenting of DNA sequences with world-wide
needs. Ultimately, of course, patenting DNA sequences became the
2
center of NIH controversy and sparked his resignation.
Watson's essay thus serves as a good lead into a final set of papers
that explore potential ethical and social consequences of the genome
project. As those papers reveal, the project has potential not only to
yield technological solutions for pressing problems but also to outstrip
our ability to regulate the technology. For example, it does not take
much imagination to envision a genetic underclass created by our
capacity to predict but not prevent various conditions, its members
being, e.g., shunned by insurers, employers and others.*
Although papers tend to repeat basic information, this welldocumented book is highly recommended for its introduction to the
technical and social aspects of an important and rapidly-evolving field.

Bradley J. Olsont
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See, e.g., Leslie Roberts, Why Watson quit as project head, 256 SCIENCE 301

(1992).
Ironically, Dr. J. Craig Venter, having a technique for identifying thousands of
genes per month, subsequently left NIH to set up his own laboratory. See, e.g.,
Gina Kolata, Biologist's Speedy Gene Method Scares PeersBut GainsBacker, New
York Times, July 28, 1992, at C1, col. 2.
* See, e.g., the review of RISKY BUSINEss ....
infra at 267 (ed.).
t Mr. Olson received his B.A. (Biology) from Central Connecticut State
University and his M.S. from the University of Connecticut. He has several years of
biochemistry laboratory experience and is a candidate for J.D. and Masters of
Intellectual Property degrees at Franklin Pierce Law Center.

